Successful treatment of invasive aspergillosis in two patients with acute myelogenous leukemia

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 3, 2003, Pages 252-256

  Singer, Melissa S ^a   Seibel, Nita L ^a   Vezina, Gilbert ^a   Choi, Sukgi S ^a   Dinndorf, Patricia A ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Acute myelogenous leukemia; Antifungal therapy; Aspergillosis; Fungal infection; Pediatric

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IDARUBICIN; ITRACONAZOLE; MICAFUNGIN; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; BONE INFECTION; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DISEASE SEVERITY; DRUG INFUSION; DRUG MEGADOSE; GRANULOCYTE TRANSFUSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; INFECTION RISK; LUNG RESECTION; MALE; NEUTROPENIA; OUTCOMES RESEARCH; PRIORITY JOURNAL; RIGOR; SURVIVAL RATE;

ADOLESCENT; AMPHOTERICIN B; ASPERGILLOSIS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFANT; LEUKEMIA, MYELOCYTIC, ACUTE; MALE;

EID: 0037336144     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200303000-00014     Document Type: Article

References (11)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781-805.
2. Choi SS, Milmoe GJ, Dinndorf PA, et al. Invasive Aspergillus sinusitis in pediatric bone marrow transplant patients. Arch Otolaryngol Head Neck Surg 1995;121:1188-92.
3. Patterson TF, Kirkpatrick WR, White M, et al. Invasive Aspergillosis. Medicine 2000;79:250-60.
4. DeShazo RD, Chapin K, Swain RE. Fungal sinusitis. N Engl J Med 1997;337: 254-9.
5. Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis 2000;30:696-709.
6. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990;12:1147-201.
7. Tawara S, Ikeda F, Maki K, et al. In Vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother 2000;44:57-62.
8. Walsh TJ, Gonzalez C, Lyman CA, et al. Invasive fungal infections in children: recent advances in diagnosis and treatment. Adv Pediatr Infect Dis 1995;11: 187-290.
9. Jones TC. Use of granulocyte-macrophage colony stimulating factor (GM-CSF) in prevention and treatment of fungal infections. Eur J Cancer 1999;35:S8-10.
10. Guiot HFL, Fibbe WE, van't Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994;18:525-32.
11. Harari S. Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients. Drugs 1999;58:621-30.